Adapt Pharma

adaptpharma.com

Adapt Pharma is an innovative small business focused on developing cutting-edge treatments for patients with special medical conditions. Our mission is to provide simple, reliable, and accessible therapeutic options, ensuring that patients, and those who care for them, have access to the right treatment at the right time.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BUSINESS INSIGHTS

BRUKER ACQUIRES OPTIMAL COMPANIES FOR PHARMA PAT SOFTWARE AND BIOPHARMA MANUFACTURING AUTOMATION EXPERTISE AND TECHNOLOGIES

Bruker Corporation | April 06, 2022

news image

Bruker Corporation announced the acquisition of Optimal Industrial Automation and Technologies, a leader in pharma and biopharma process analytical technology pharma manufacturing automation and Quality Assurance (QA) software and systems integration, based in the United Kingdom. The Optimal biopharma tools acquisition strengthens Bruker as a key software and solutions provider for small molecule, biologics and new drug modalities pharma companies. Financial details of the acquisi...

Read More

BUSINESS INSIGHTS

BASETWO LAUNCHES NO-CODE ARTIFICIAL INTELLIGENCE PLATFORM FOR PHARMACEUTICAL MANUFACTURING, RAISES $3.8 MILLION

Basetwo | May 27, 2022

news image

Basetwo, a SaaS AI platform for manufacturers, announced it secured a $3.8M seed round led by Glasswing Ventures and Argon Ventures with additional funding from Caffeinated Capital, Graphite Ventures, MaRs IAF, Pareto Holdings, Plug and Play, and Quiet Capital. The funding supports the launch of the category-making Basetwo AI platform, a first-of-its-kind solution that enables process engineers to rapidly build digital twins of their manufacturing plants leveraging a familiar no-c...

Read More

BUSINESS INSIGHTS

ACULYS PHARMA AND SUSMED HAVE ENTERED INTO A CONTRACT TO CONDUCT THE WORLD'S FIRST CLINICAL TRIAL UTILIZING BLOCKCHAIN TECHNOLOGY

Aculys Pharma, Inc. | July 13, 2022

news image

Aculys Pharma, Inc. a company focused on the development and commercialization of new innovative drugs in the fields of neurology and psychiatry, has entered into a contract with SUSMED, Inc., a company that promotes digital medicine to conduct the world's first1 corporate-sponsored clinical trial using blockchain technology. The clinical trial utilizing this blockchain technology, provided by SUSMED, will be conducted in collaboration with CMIC Co., Ltd., a pioneer in drug development suppo...

Read More

PHARMA TECH

SPECIFICA ANNOUNCES ANTIBODY DISCOVERY PLATFORM TRANSFER AGREEMENT WITH SANOFI

Specifica | June 03, 2022

news image

Specifica, a privately held antibody engineering company focused on innovative in vitro antibody libraries and discovery tools, announced an agreement with the global healthcare company Sanofi under which Specifica’s patented Generation 3 Antibody Discovery Platform will be transferred to Sanofi. The comprehensive technology transfer package will enable the integration of Specifica’s Gen 3 platform into Sanofi’s antibody discovery programs. “<...

Read More
news image

BUSINESS INSIGHTS

BRUKER ACQUIRES OPTIMAL COMPANIES FOR PHARMA PAT SOFTWARE AND BIOPHARMA MANUFACTURING AUTOMATION EXPERTISE AND TECHNOLOGIES

Bruker Corporation | April 06, 2022

Bruker Corporation announced the acquisition of Optimal Industrial Automation and Technologies, a leader in pharma and biopharma process analytical technology pharma manufacturing automation and Quality Assurance (QA) software and systems integration, based in the United Kingdom. The Optimal biopharma tools acquisition strengthens Bruker as a key software and solutions provider for small molecule, biologics and new drug modalities pharma companies. Financial details of the acquisi...

Read More
news image

BUSINESS INSIGHTS

BASETWO LAUNCHES NO-CODE ARTIFICIAL INTELLIGENCE PLATFORM FOR PHARMACEUTICAL MANUFACTURING, RAISES $3.8 MILLION

Basetwo | May 27, 2022

Basetwo, a SaaS AI platform for manufacturers, announced it secured a $3.8M seed round led by Glasswing Ventures and Argon Ventures with additional funding from Caffeinated Capital, Graphite Ventures, MaRs IAF, Pareto Holdings, Plug and Play, and Quiet Capital. The funding supports the launch of the category-making Basetwo AI platform, a first-of-its-kind solution that enables process engineers to rapidly build digital twins of their manufacturing plants leveraging a familiar no-c...

Read More
news image

BUSINESS INSIGHTS

ACULYS PHARMA AND SUSMED HAVE ENTERED INTO A CONTRACT TO CONDUCT THE WORLD'S FIRST CLINICAL TRIAL UTILIZING BLOCKCHAIN TECHNOLOGY

Aculys Pharma, Inc. | July 13, 2022

Aculys Pharma, Inc. a company focused on the development and commercialization of new innovative drugs in the fields of neurology and psychiatry, has entered into a contract with SUSMED, Inc., a company that promotes digital medicine to conduct the world's first1 corporate-sponsored clinical trial using blockchain technology. The clinical trial utilizing this blockchain technology, provided by SUSMED, will be conducted in collaboration with CMIC Co., Ltd., a pioneer in drug development suppo...

Read More
news image

PHARMA TECH

SPECIFICA ANNOUNCES ANTIBODY DISCOVERY PLATFORM TRANSFER AGREEMENT WITH SANOFI

Specifica | June 03, 2022

Specifica, a privately held antibody engineering company focused on innovative in vitro antibody libraries and discovery tools, announced an agreement with the global healthcare company Sanofi under which Specifica’s patented Generation 3 Antibody Discovery Platform will be transferred to Sanofi. The comprehensive technology transfer package will enable the integration of Specifica’s Gen 3 platform into Sanofi’s antibody discovery programs. “<...

Read More